Clinical Laboratory Testing Services Market: By Specialty Testing, Specialized Chemistry Testing, Other Clinical Chemistry Testing), By Microbiology Testing, Hematology Testing, Immunology Testing, Cytology Testing, Genetic Testing, and Drug of Abuse Testing), By Provider and Region Forecast 2019-2030
Clinical laboratory testing services market size was valued at US$ 230.2 billion in 2023 and is poised to grow at a significant CAGR of 3.6% from 2024-2030. The market is expected to grow during the projected period due to the quick technical improvements to increase productivity and lower prices. For instance, in 2019, a new pre-pregnancy comprehensive carrier screening test from Australian Clinical Labs was introduced, it covers more inherited genetic diseases than its predecessor in less time. Clinical laboratories frequently adopt international standards, opening up the potential for automation and interoperability.
For instance, in November 2020, Co-Diagnostics, Inc. and CoSara Diagnostics Pvt. Ltd. received approval from the Central Drugs Standard Control Organization (CDSCO) to make and distribute the Saragene COVID-19 2-gene multiplex RT-PCR test in India.
Furthermore, market companies are working on launching innovative services to meet patients' unmet needs. For instance, in July 2020, cGMP-compatible CTS Series Laboratory Equipment was introduced by Thermo Fisher Scientific, Inc. The tools include a wide range of lab tools commonly employed in producing gene and cell therapies, such as centrifuges, CO2 incubators, and biological safety cabinets. The market for clinical laboratory testing services is also anticipated to be driven by an increase in at-home testing for illness diagnosis and routine health condition monitoring.
In addition, key players in the independent laboratory trend are heavily consolidating as they concentrate on strategic alliances and collaborations, which is expected to propel the market's expansion. For instance, in October 2020, CENTOGENE, a significant provider of COVID-19 testing in Germany, teamed up with U-Diagnostics, a diagnostic laboratory in the Netherlands, to expand COVID testing services throughout the Netherlands. Additionally, in July 2020, Targos Molecular Pathology and HistoCyte Laboratories joined forces with Diaceutics PLC, a company specializing in diagnostic network solutions for developing and commercializing precision medicine diagnostics, to improve and expand diagnostic testing services in 2,500 labs worldwide. Therefore, the overall market for clinical laboratory services is growing due to all these advancements.
Study Period
2024-2030Base Year
2023CAGR
3.6%Largest Market
Asia-PacificFastest Growing Market
North America
The demand for clinical diagnostics is anticipated to benefit from the rising burden of cancer. For instance, according to the Global Cancer Observatory's (Globocan) Statistics 2020, there were 19.3 million new cancer cases worldwide in 2020, including both sexes. The same source also stated that the incidence of cancer is rising quickly worldwide, and it is foreseen that by 2040, there will be 30.2 million new cancer cases worldwide, including both sexes.
Therefore, market players are concentrating on technical upgrades of their goods to have a competitive edge over the other competitors, which will further augment the market's growth due to the growing burden of the target diseases. On the other hand, market growth is anticipated to be constrained by pricing pressure experienced by healthcare payers and providers and the transition from lab-based diagnosis to home-based/point-of-care testing techniques.
The clinical laboratory testing services market in North America is likely to hold a significant revenue share in 2022, and, in the following years, it is predicted to increase rapidly. Due to the country's high prevalence of chronic diseases and the necessity for clinical laboratory testing services for effective patient care, the United States is expected to experience significant growth within the region. Other significant factors propelling the expansion of the studied market in the North American region include the high burden of chronic and targets diseases in the area and the rising desire for early diagnosis. For instance, the Canadian Cancer Society's 2021 study estimated that there would be roughly 229,200 new cancer cases in Canada that year. Additionally, on average, 628 Canadians are already diagnosed with cancer every day, and this number is likely to rise in the coming years.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 230.2 billion |
|
Market CAGR |
3.6% |
|
By Specialty |
|
|
By Provider |
|
|
By Region |
|
Download Free Sample Report
The clinical laboratory testing services market size was valued at US$ 230.2 billion in 2023 and is poised to grow at a significant CAGR of 3.6% over 2024-2030
NeoGenomics Laboratories, Inc., Fresenius Medical Care, DaVita, Inc., Siemens Healthcare GmbH, Viapath Group LLP, SGS SA, Almac Group
North America is the fastest-growing region in the market
| 1.Executive Summary |
| 2.Global Clinical Laboratory Testing Services Market Introduction |
| 2.1.Global Clinical Laboratory Testing Services Market - Taxonomy |
| 2.2.Global Clinical Laboratory Testing Services Market - Definitions |
| 2.2.1. By Specialty |
| 2.2.2. By Provider |
| 2.2.3. By Region |
| 3.Global Clinical Laboratory Testing Services Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Clinical Laboratory Testing Services Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Clinical Laboratory Testing Services Market By Specialty, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Clinical Chemistry Testing |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Microbiology Testing |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Hematology Testing |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Immunology Testing |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Cytology Testing |
| 5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Genetic Testing |
| 5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 5.7. Drug of Abuse Testing |
| 5.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.7.3. Market Opportunity Analysis |
| 6.Global Clinical Laboratory Testing Services Market By Provider, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Independent and Reference Laboratories |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Hospital-based Laboratories |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Nursing and Physician Office-based Laboratories |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7.Global Clinical Laboratory Testing Services Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.North America Clinical Laboratory Testing Services Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Specialty Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Clinical Chemistry Testing |
| 8.1.2.Microbiology Testing |
| 8.1.3.Hematology Testing |
| 8.1.4.Immunology Testing |
| 8.1.5.Cytology Testing |
| 8.1.6.Genetic Testing |
| 8.1.7.Drug of Abuse Testing |
| 8.2. Provider Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Independent and Reference Laboratories |
| 8.2.2.Hospital-based Laboratories |
| 8.2.3.Nursing and Physician Office-based Laboratories |
| 8.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9.Europe Clinical Laboratory Testing Services Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Specialty Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Clinical Chemistry Testing |
| 9.1.2.Microbiology Testing |
| 9.1.3.Hematology Testing |
| 9.1.4.Immunology Testing |
| 9.1.5.Cytology Testing |
| 9.1.6.Genetic Testing |
| 9.1.7.Drug of Abuse Testing |
| 9.2. Provider Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Independent and Reference Laboratories |
| 9.2.2.Hospital-based Laboratories |
| 9.2.3.Nursing and Physician Office-based Laboratories |
| 9.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 10.Asia Pacific (APAC) Clinical Laboratory Testing Services Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Specialty Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Clinical Chemistry Testing |
| 10.1.2.Microbiology Testing |
| 10.1.3.Hematology Testing |
| 10.1.4.Immunology Testing |
| 10.1.5.Cytology Testing |
| 10.1.6.Genetic Testing |
| 10.1.7.Drug of Abuse Testing |
| 10.2. Provider Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Independent and Reference Laboratories |
| 10.2.2.Hospital-based Laboratories |
| 10.2.3.Nursing and Physician Office-based Laboratories |
| 10.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11.Middle East and Africa (MEA) Clinical Laboratory Testing Services Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Specialty Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Clinical Chemistry Testing |
| 11.1.2.Microbiology Testing |
| 11.1.3.Hematology Testing |
| 11.1.4.Immunology Testing |
| 11.1.5.Cytology Testing |
| 11.1.6.Genetic Testing |
| 11.1.7.Drug of Abuse Testing |
| 11.2. Provider Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Independent and Reference Laboratories |
| 11.2.2.Hospital-based Laboratories |
| 11.2.3.Nursing and Physician Office-based Laboratories |
| 11.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12.Latin America Clinical Laboratory Testing Services Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Specialty Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Clinical Chemistry Testing |
| 12.1.2.Microbiology Testing |
| 12.1.3.Hematology Testing |
| 12.1.4.Immunology Testing |
| 12.1.5.Cytology Testing |
| 12.1.6.Genetic Testing |
| 12.1.7.Drug of Abuse Testing |
| 12.2. Provider Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Independent and Reference Laboratories |
| 12.2.2.Hospital-based Laboratories |
| 12.2.3.Nursing and Physician Office-based Laboratories |
| 12.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Qiagen |
| 13.2.2.Quest Diagnostics, Inc. |
| 13.2.3.OPKO Health, Inc. |
| 13.2.4.Abbott |
| 13.2.5.Charles River Laboratories International, Inc. |
| 13.2.6.Cinven |
| 13.2.7.Arup Laboratories |
| 13.2.8.Sonic Healthcare |
| 13.2.9.Laboratory Corporation of America Holdings (LabCorp) |
| 13.2.10.NeoGenomics Laboratories, Inc. |
| 13.2.11.Fresenius Medical Care |
| 13.2.12.DaVita, Inc. |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Free Sample
